Why is PCT after a cycle containing two 19-nor compounds more intensive than after testosterone-only cycles?

PCT is more demanding because both Trenbolone Acetate and Nandrolone Decanoate suppress the HPG axis through progestogenic pathways in addition to androgen-receptor-mediated suppression. This dual mechanism frequently elevates prolactin, which a standard SERM alone cannot address. Most harm-reduction protocols therefore combine a SERM with a dopamine agonist such as cabergoline to manage prolactin alongside oestrogen rebound.

When should HCG be introduced before starting SERM therapy after a Genesis Mix Products Injection cycle?

HCG is typically introduced in the final 2–3 weeks of the active cycle, or immediately after the last injection before SERM initiation, to resensitise Leydig cells that have been suppressed by the dual 19-nor and testosterone components. Starting HCG at 500–1000 IU every other day for 10–14 days prior to SERM commencement can significantly improve HPTA responsiveness and shorten overall recovery time.

How long does HPTA recovery generally take after an extended microdosing cycle with a long-ester 19-nor compound?

HPTA recovery following prolonged dual 19-nor exposure typically ranges from 8 to 16 weeks, depending on cycle length, total dose, and individual responsiveness. The Nandrolone Decanoate component's approximately 12-day half-life means active suppression continues for several weeks after the last injection, extending the recovery timeline compared to short-ester-only cycles. Regular LH, FSH, and testosterone bloodwork every 4 weeks tracks recovery progress objectively.

Can the 10ml multi-dose vial of Genesis Mix Products Injection be drawn with an insulin syringe for microdosing purposes?

Yes — the 250mg/ml concentration and multi-dose vial format are compatible with insulin-gauge (29–31G) syringe draws for subcutaneous or shallow intramuscular microdose administration. Using a 0.3–0.5ml draw per injection delivers 75–125mg of total active blend per microdose. The oil-based vehicle must be pre-warmed to body temperature for 1–2 minutes to reduce viscosity and ensure smooth flow through a fine-gauge needle.

How should the Genesis Mix Products Injection vial be stored after first opening to maintain concentration integrity?

After first puncture, the vial should be stored upright at 15–25°C away from direct light; refrigeration is not required but is acceptable. Each draw must use a new sterile needle to avoid contaminating the remaining contents. Genesis's LAL endotoxin testing and sealed multi-dose stoppers are designed for repeated puncture, but opened vials should be used within 28 days and discarded if any cloudiness, particulate matter, or colour change is observed. (2) angle_used

Recomp Optimizer

Genesis

Mix Products Injection 250mg/ml 10ml Vial by Genesis

Name: Mix Products Injection 250mg/ml 10ml Vial by Genesis
Brand: Genesis
SKU: INJ-MIX-GES-250-002
Price: 54.00 EUR
Availability: InStock

Genesis Mix Products Injection is a 250mg/ml tri-ester hybrid injectable combining Trenbolone Acetate 40mg, Nandrolone Decanoate 90mg, and Testosterone Mix 120mg per ml, formulated specifically to support precise microdosing protocols in a 10ml multi-dose vial. The dual 19-nor structure combined with a testosterone base makes post-cycle therapy exceptionally demanding — users must expect an aggressive, extended SERM regimen beginning approximately 14–21 days after the final injection, timed to the decanoate ester's clearance. Vial integrity, concentration accuracy, and sterility are verified through reversed-phase HPLC quantification and LAL endotoxin testing; every released batch carries a traceable certificate of analysis.

€54.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Three pharmacokinetically distinct esters activate short, medium, and long anabolic windows from a single microdose injection.
Trenbolone Acetate fraction provides rapid nitrogen retention with minimal aromatisation, supporting lean tissue preservation during recomposition.
Nandrolone Decanoate component contributes documented collagen synthesis support and joint-cushioning properties across the dosing interval.
Testosterone Mix base maintains physiological androgen presence and supports libido throughout the suppressive cycle.
250mg/ml concentration enables sub-ml microdose volumes drawn precisely with a fine-gauge syringe — minimal injection-site discomfort.
Single 10ml vial delivers 2,500mg total active compound, sufficient for a complete structured microdosing protocol without mid-cycle restocking.
Genesis batch-level HPLC and LAL endotoxin verification ensures consistent concentration and sterility across every multi-dose draw.

Phase	Microdose Volume	Approximate Active per Injection	Frequency	Notes
Introductory (weeks 1–2)	0.3ml	75mg total blend (Tren Ace ~12mg / ND ~27mg / Test Mix ~36mg)	Every 2 days	Assess tolerability; monitor prolactin and haematocrit at baseline
Maintenance (weeks 3–10)	0.4–0.5ml	100–125mg total blend	Every 2 days	Stable serum levels via frequent small injections; confirm bloodwork at week 4
Taper (weeks 11–12)	0.2–0.3ml	50–75mg total blend	Every 2–3 days	Gradual reduction before PCT initiation; do not abruptly cease
PCT window	—	—	Starts 14–21 days post-last injection	Governed by Nandrolone Decanoate's ~12-day half-life; combine SERM + dopamine agonist

Key takeaways

Split weekly totals into daily microdoses to flatten serum peaks.
Initiate PCT 14–21 days post-injection guided by decanoate clearance.
Combine a SERM with a dopamine agonist for dual 19-nor suppression.
Pre-warm the vial before insulin-syringe draws for smooth delivery.
Confirm HPTA recovery with LH, FSH, and testosterone bloodwork every four weeks.

Genesis Mix Products Injection: A Precision Microdosing Tri-Ester Blend

Genesis Mix Products Injection delivers 250mg/ml as a deliberate three-component formula — Trenbolone Acetate 40mg, Nandrolone Decanoate 90mg, and Testosterone Mix 120mg — engineered so that each fraction fulfils a distinct pharmacokinetic role within a structured microdosing strategy. Compared to single-ester injectables administered at full weekly volumes, a microdosing approach with this blend spreads equivalent weekly totals across more frequent, smaller injections, flattening the peak-to-trough serum curve and reducing acute androgenic burden per dose. The Trenbolone Acetate fraction (approximately 2–3 day half-life) provides rapid anabolic signalling following each microdose, while the Nandrolone Decanoate fraction (approximately 12-day half-life, confirmed by established pharmacokinetic modelling) maintains a sustained anabolic base between administrations.

How the Three Esters Divide Labour in a Microdosing Protocol

The Testosterone Mix component — comprising mixed short-to-medium esters — acts as the endocrine foundation, partially offsetting HPG-axis suppression and supporting physiological androgen levels across the dosing interval. Genesis Mix Products Injection contains two 19-nor anabolic agents simultaneously: Nandrolone Decanoate contributes documented collagen synthesis support and joint-protective properties through progesterone-receptor partial agonism, while Trenbolone Acetate drives nitrogen retention at the myofibrillar level without significant aromatisation. These three fractions allow a single sub-ml microdose injection — drawn via an insulin-gauge syringe — to activate short-, medium-, and long-acting anabolic pathways simultaneously, a pharmacokinetic efficiency no single-ester compound can replicate.

PCT Complexity After a Dual 19-Nor Microdosing Cycle

Post-cycle therapy following this formulation is structurally more demanding than after single-compound cycles. Because both Trenbolone Acetate and Nandrolone Decanoate exert progestogenic HPG suppression, SERM monotherapy is generally insufficient; clinical practice in harm-reduction literature recommends combining a selective oestrogen receptor modulator with a dopamine agonist (e.g. cabergoline) to address prolactin-mediated suppression. PCT initiation is governed by the longest ester present — Nandrolone Decanoate's approximately 12-day half-life — placing the recommended SERM start window at 14–21 days post-final injection. The 10ml vial provides 2,500mg total active ingredient, giving experienced users a full microdosing cycle from a single unit; Genesis batch documentation — verified by HPLC and LAL endotoxin assay — ensures concentration consistency across every draw.

Usage

Verify the vial: Confirm the Genesis holographic label and batch code before first draw; cross-reference against the certificate of analysis for HPLC-verified concentration.
Pre-warm the oil: Hold the sealed vial in your closed hand or under warm running water for 60–90 seconds to reduce viscosity, ensuring full draw with a fine-gauge (29–31G) insulin syringe.
Draw with a filter needle, inject with a fine needle: Use a 18G needle to draw the measured microdose volume, then swap to a 29–31G needle for subcutaneous or shallow IM injection to minimise injection-site reaction.
Rotate injection sites systematically: Microdosing frequency (every 2 days) demands strict site rotation — abdomen, lateral thigh, and deltoid — to prevent subcutaneous fibrosis from repeated puncture.
Log each dose and monitor biomarkers: Record injection time, volume, and site; schedule bloodwork (LH, FSH, prolactin, haematocrit, liver enzymes) at weeks 4 and 8 to catch progestogenic side effects early.
Plan PCT before starting: Calculate PCT start date based on your final scheduled injection plus 14–21 days; have SERM and dopamine agonist on hand before cycle commencement, not after it ends.

Warnings

Contraindications

: Not suitable for individuals under 21, those with prostate or breast carcinoma, elevated haematocrit (>52%), untreated hypertension, active hepatic impairment, or a history of hypersensitivity to any ester component. Women of childbearing potential should not use this product due to virilisation risk.

Side Effects

: The dual 19-nor structure elevates prolactin and carries progestogenic activity — monitor for galactorrhoea and sexual dysfunction. Trenbolone Acetate may cause night sweats, elevated resting heart rate, and reduced cardiovascular endurance. Nandrolone Decanoate suppresses HPTA deeply; expect suppressed endogenous testosterone throughout the cycle. Testosterone aromatisation from the mix fraction may require an aromatase inhibitor.

Monitoring

: Baseline and mid-cycle bloodwork should include: prolactin, LH, FSH, total and free testosterone, haematocrit, lipid panel, and liver enzymes. Blood pressure should be tracked weekly. Any visual disturbances or severe mood changes warrant immediate cycle cessation and medical evaluation.

PCT

: Begin SERM therapy 14–21 days after the last injection — the Nandrolone Decanoate ester (~12-day half-life) dictates this window. Combine a SERM (e.g. Nolvadex or Clomid) with a dopamine agonist (e.g. cabergoline 0.5mg twice weekly) to address prolactin suppression alongside oestrogen rebound. HCG pre-loading (500–1000 IU EOD for 10–14 days before SERM start) is strongly recommended after cycles exceeding 10 weeks.

Frequently asked questions

Why is PCT after a cycle containing two 19-nor compounds more intensive than after testosterone-only cycles?: PCT is more demanding because both Trenbolone Acetate and Nandrolone Decanoate suppress the HPG axis through progestogenic pathways in addition to androgen-receptor-mediated suppression. This dual mechanism frequently elevates prolactin, which a standard SERM alone cannot address. Most harm-reduction protocols therefore combine a SERM with a dopamine agonist such as cabergoline to manage prolactin alongside oestrogen rebound.
When should HCG be introduced before starting SERM therapy after a Genesis Mix Products Injection cycle?: HCG is typically introduced in the final 2–3 weeks of the active cycle, or immediately after the last injection before SERM initiation, to resensitise Leydig cells that have been suppressed by the dual 19-nor and testosterone components. Starting HCG at 500–1000 IU every other day for 10–14 days prior to SERM commencement can significantly improve HPTA responsiveness and shorten overall recovery time.
How long does HPTA recovery generally take after an extended microdosing cycle with a long-ester 19-nor compound?: HPTA recovery following prolonged dual 19-nor exposure typically ranges from 8 to 16 weeks, depending on cycle length, total dose, and individual responsiveness. The Nandrolone Decanoate component's approximately 12-day half-life means active suppression continues for several weeks after the last injection, extending the recovery timeline compared to short-ester-only cycles. Regular LH, FSH, and testosterone bloodwork every 4 weeks tracks recovery progress objectively.
Can the 10ml multi-dose vial of Genesis Mix Products Injection be drawn with an insulin syringe for microdosing purposes?: Yes — the 250mg/ml concentration and multi-dose vial format are compatible with insulin-gauge (29–31G) syringe draws for subcutaneous or shallow intramuscular microdose administration. Using a 0.3–0.5ml draw per injection delivers 75–125mg of total active blend per microdose. The oil-based vehicle must be pre-warmed to body temperature for 1–2 minutes to reduce viscosity and ensure smooth flow through a fine-gauge needle.
How should the Genesis Mix Products Injection vial be stored after first opening to maintain concentration integrity?: After first puncture, the vial should be stored upright at 15–25°C away from direct light; refrigeration is not required but is acceptable. Each draw must use a new sterile needle to avoid contaminating the remaining contents. Genesis's LAL endotoxin testing and sealed multi-dose stoppers are designed for repeated puncture, but opened vials should be used within 28 days and discarded if any cloudiness, particulate matter, or colour change is observed. (2) angle_used

Manufacturer

Genesis's packaging and container strategy for its injectable line reflects a philosophy built around multi-dose practicality rather than single-use convenience — and the 10ml stoppered vial format used for Mix Products Injection 250mg/ml is the clearest expression of that approach. The multi-dose vial is not simply a larger ampule: Genesis specifies a chlorobutyl stopper compound selected for repeated puncture resistance and chemical compatibility with the oil-based carrier vehicle, properties that single-break glass ampules cannot offer. Each vial undergoes integrity testing — headspace gas analysis confirming absence of oxygen ingress — before label application, ensuring that the sterile nitrogen environment inside the container is intact at the point of use. The label itself carries a batch-traceable alphanumeric code that links back to the corresponding certificate of analysis, giving users direct access to the HPLC concentration report and LAL endotoxin result for their specific production lot. This traceability chain — from container integrity check through analytical release documentation to the end user's hands — is Genesis's answer to the quality ambiguity that multi-dose vials have historically attracted in the injectable anabolic category.

Product details

Brand	Genesis
Active ingredient	mix product
Also known as	Steroid-Mix, Mehrkomponenten-Mischung, Cut Mix, Gain Mix, Mix Products Injection, Genesis Steroid-Mix
Strength	250 mg
Form	Vial
Pack size	1 piece
Item number	INJ-MIX-GES-250-002

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Mixobolin-200 200mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Hardcore Cutting

Mixobolin-200 200mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Mixobolin-200 by BM Pharmaceuticals combines Trenbolone Acetate 50mg, Drostanolone Propionate 50mg, and Testosterone Propionate 100mg per millilitre — 200mg/ml total — across 10 individually sealed single-dose glass ampoules, formulated to distribute androgen receptor occupancy across three mechanistically distinct compound classes rather than concentrating binding pressure through a single high-affinity pathway. All three propionate and acetate esters clear within 2–3 days, allowing cycle termination to be executed precisely when training output signals diminishing receptor responsiveness, with post-cycle therapy starting as early as 3–5 days after the final ampoule. Per-compound HPLC quantification and LAL endotoxin screening are applied at batch level; each ampoule is hermetically sealed under nitrogen-blanketed aseptic fill conditions before carton assembly.

€76.00

Mass Building

NTD 400 400mg/ml 10ml Vial by GenTec

GenTec NTD 400 is a 400mg/ml tri-ester injectable blend — Nandrolone Decanoate 100mg, Drostanolone Enanthate 100mg, Testosterone Enanthate 200mg — formulated specifically for cruise & blast mass-building protocols in a 10ml multi-dose vial. Each millilitre delivers 4,000mg of total active ingredient across the full vial, with long-acting esters sustaining stable plasma levels throughout extended blast phases without the need for daily injections. Quality assurance is enforced through HPLC concentration verification, LAL endotoxin testing, and GMP-compliant aseptic fill-and-finish; batch certificates are available per lot.

€50.00

Best Value

Cut Stack 150 150mg/ml 10ml Vial by Hilma Biocare

Cut Stack 150 by Hilma Biocare is a 150mg/ml injectable cutting blend — Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml — supplied in a 10ml multi-dose vial and formulated exclusively for advanced cutting protocols, with an absolute contraindication against TRT or anti-aging use. Because all three compounds carry a 2–3 day half-life, plasma levels fall to sub-suppressive thresholds within days of the final injection, opening the post-cycle recovery window approximately 3–5 days after the last dose — a materially earlier point than long-ester injectable cycles, and driven by ester hydrolysis rather than the hepatic clearance kinetics that govern oral-cycle PCT scheduling. Every production lot is released under Hilma Biocare's analytical framework: HPLC potency confirmation and LAL endotoxin testing applied batch-by-batch, with certificates accessible via the brand's verification portal.

€54.00

Cutting Specialist

Cutaxyl 150 150mg/ml 10ml Vial by Kalpa Pharmaceuticals

Cutaxyl 150 is a GMP-certified tri-ester cutting injectable by Kalpa Pharmaceuticals, combining Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml in a single 10ml multi-dose vial at 150mg/ml total concentration — formulated for compliance-conscious experienced users who demand jurisdiction-verified PCT readiness before the first injection is drawn. All three compounds carry short acetate and propionate ester chains, enabling post-cycle therapy to be scheduled as early as 3–5 days after the final dose, though SERM legal and prescription status varies materially across national regulatory frameworks and must be confirmed in advance. Each production batch exits Kalpa Pharmaceuticals' GMP facility with HPLC-verified active-ingredient concentration, LAL endotoxin clearance, and batch-traceable documentation linked to a specific, dateable manufacturing event.

€52.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00